Chester County News and Community Website
LANGHORNE, PA — Savara (Nasdaq: SVRA) reported long-term Phase 3 trial data showing continued improvements in lung function and respiratory quality of life among patients receiving molgramostim for autoimmune pulmonary …
Savara Reports Long-Term Phase 3 Data Supporting Molgramostim Durability Read More
WASHINGTON, D.C. — The Department of Veterans Affairs is launching a clinical trial of MDMA-assisted therapy for veterans with post-traumatic stress disorder and alcohol use disorder, expanding federal research into …
VA Launches MDMA Trial for PTSD, Alcohol Use Disorders Read More LANGHORNE, PA — Savara (Nasdaq: SVRA) reported new Phase 3 clinical trial data showing patients treated with its experimental inhaled therapy molgramostim achieved greater improvements in exercise capacity than those …
Savara Reports Phase 3 Data Showing Exercise Gains in Rare Lung Disease Trial Read More
PHILADELPHIA, PA — iECURE said new data from its ongoing OTC-HOPE clinical trial showed sustained clinical benefit in the first infant treated with its experimental gene-editing therapy ECUR-506 and statistically …
iECURE Reports Early Clinical Gains in OTC Gene Therapy Trial Read More
PLYMOUTH MEETING, PA — INOVIO (Nasdaq: INO) moved closer to a potential commercial milestone in China after its licensing partner ApolloBio reported positive Phase 3 results for VGX-3100, an investigational …
INOVIO Partner Reports Phase 3 Success for HPV Therapy in China Read More
WAYNE, PA — Palvella Therapeutics (Nasdaq: PVLA) reported new late-stage clinical data showing strong patient response rates for its experimental QTORIN rapamycin treatment in rare vascular malformations, positioning the company …
Palvella Reports Late-Stage Success for Rare Disease Drug Read More
LANGHORNE, PA — NEXGEL, Inc. (Nasdaq: NXGL) released clinical study data showing its hydrogel patch reduced airborne particulate exposure during laser hair removal procedures, as healthcare providers and regulators increase …
NEXGEL Study Targets Safety Risks in Laser Hair Removal Read More
KING OF PRUSSIA, PA — SEED Therapeutics, Inc. will present early clinical and preclinical data for its experimental cancer therapy ST-01156 at the upcoming 2026 American Society of Clinical Oncology …
SEED Therapeutics Advances RBM39 Cancer Drug Into Phase 1 Read More
WILMINGTON, DE — AstraZeneca (LSE/STO/NYSE: AZN) reported positive Phase III trial results showing its immunotherapy IMFINZI combined with enfortumab vedotin improved survival outcomes for certain muscle-invasive bladder cancer patients unable …
AstraZeneca Trial Extends Survival in Bladder Cancer Study Read More PHILADELPHIA, PA — iECURE, Inc. reported preliminary clinical data showing its experimental gene-editing therapy reduced life-threatening metabolic crises in infants with severe ornithine transcarbamylase deficiency, offering early evidence of efficacy …
iECURE Gene Therapy Data Show Fewer Metabolic Crises Read More